Skip to content

Clinical trials

Hereditary Sensory and Autonomic Neuropathies trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hereditary Sensory and Autonomic Neuropathies Country / region: United Kingdom Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20124
20171
20184
20191
20201
20213
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated3
Recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AstraZeneca3
Artios Pharma Ltd1
Bayer1
Bristol-Myers Squibb1
Dompé Farmaceutici S.p.A1
EMD Serono Research & Development Institute, Inc.1
Incyte Corporation1
King's College London1
Merck KGaA, Darmstadt, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hereditary Sensory and Autonomic Neuropathies20
Breast Neoplasms4
Neoplasm Metastasis3
Ovarian Neoplasms3
Endometrial Neoplasms2
Neoplasms2
Angiomyolipoma1
Astrocytoma1
Ataxia Telangiectasia1
Brain Neoplasms1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.